[
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "What happens to the expression of the Braveheart genes in embryonic stem cells and differentiating heart cells?\n\nAnswer Choices:\nA. It increases in both cell types.\nB. It decreases in both cell types. \nC. It increases in embryonic stem cells and decreases in differentiating heart cells. \nD. It decreases in embryonic cells and slightly increases in differentiating heart cells. \nE. It increases in embryonic cells and is unchanged in differentiating heart cells. \nF. It does not change in both cell types"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762206242-kJAzSuI7bowYn6J3DYWV",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"D. It decreases in embryonic cells and slightly increases in differentiating heart cells.\",\"answer_letter\":\"D\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Analyzing stem cells and gene expression**\n\nI'm considering two components: embryonic stem cells and differentiating heart cells. I think that could mean a likely pattern of increasing differentiating heart cells while embryonic cells decrease. But now I'm wondering about the expression of the Braveheart genes in these cells over time. \n\nLooking at the data, it seems Bvht expression decreases in embryonic stem cells and slightly increases in differentiating heart cells. The qRT-PCR data might show that expression initially peaks around day 6 during differentiation. It\u2019s all quite intricate!**Evaluating gene expression options**\n\nI'm weighing different options about the expression of Braveheart genes in embryonic stem cells and differentiating heart cells. Option C contradicts my understanding, and Option E seems unlikely as well. Option A, which suggests increases in both cell types, doesn\u2019t quite add up. I think the phrasing implies that expression decreases in embryonic stem cells, while in differentiating heart cells, it increases slightly. Referring back to the Klattenhoff abstract, it clarifies that Bvht is necessary for the developing heart, confirming low expression in ESCs but higher in differentiating heart cells. So, D seems to fit best!**Clarifying gene expression changes**\n\nI'm considering the phrasing \"decreases in embryonic cells,\" but I\u2019m unsure what it's decreasing compared to. Maybe this exam question is addressing Braveheart genes, which are epigenetically regulated. In embryonic stem cells, their expression is likely repressed, and in differentiating heart cells, it's activated, suggesting that the correct answer could be D. However, the expression is low in ESCs, which makes \"decreases in embryonic cells\" a bit ambiguous. I think the best interpretation is that it decreases relative to higher levels in differentiating heart cells. So the answer likely states that expression increases in those cells.**Evaluating expression changes in options**\n\nOption D suggests that expression decreases in embryonic cells and slightly increases in differentiating heart cells, which implies low expression in embryonic cells and a slight increase elsewhere. But, I wonder, is this \"decrease\" relative to a baseline? Checking other options reveals B says decreases in both, F indicates no change, C suggests increases in embryonic stem cells but decreases in heart cells, and E claims increases in embryonic cells with unchanged heart cells. D could fit if interpreted as a decrease over time, but is that really what it means? Maybe the user is referencing multiple \"Braveheart genes,\" implying regulation by the Braveheart lncRNA.**Interpreting Braveheart gene expression**\n\nThe question asks what happens to Braveheart genes in embryonic stem cells (ESCs) and differentiating heart cells. It seems the term \"Braveheart genes\" might not be standard, but I could be looking at a graph showing high expression in ESCs that decreases during differentiation. \n\nOption B suggests decreases in both cell types, which feels improbable since Bvht expression actually increases during cardiac differentiation. Therefore, I think D is the best choice: it states expression decreases in embryonic cells and slightly increases in differentiating heart cells, which aligns with the idea that Braveheart-regulated genes are low in ESCs and upregulated during differentiation. So I'll go with D, providing a brief rationale for my selection.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Analyzing stem cells and gene expression**\n\nI'm considering two components: embryonic stem cells and differentiating heart cells. I think that could mean a likely pattern of increasing differentiating heart cells while embryonic cells decrease. But now I'm wondering about the expression of the Braveheart genes in these cells over time. \n\nLooking at the data, it seems Bvht expression decreases in embryonic stem cells and slightly increases in differentiating heart cells. The qRT-PCR data might show that expression initially peaks around day 6 during differentiation. It\u2019s all quite intricate!**Evaluating gene expression options**\n\nI'm weighing different options about the expression of Braveheart genes in embryonic stem cells and differentiating heart cells. Option C contradicts my understanding, and Option E seems unlikely as well. Option A, which suggests increases in both cell types, doesn\u2019t quite add up. I think the phrasing implies that expression decreases in embryonic stem cells, while in differentiating heart cells, it increases slightly. Referring back to the Klattenhoff abstract, it clarifies that Bvht is necessary for the developing heart, confirming low expression in ESCs but higher in differentiating heart cells. So, D seems to fit best!**Clarifying gene expression changes**\n\nI'm considering the phrasing \"decreases in embryonic cells,\" but I\u2019m unsure what it's decreasing compared to. Maybe this exam question is addressing Braveheart genes, which are epigenetically regulated. In embryonic stem cells, their expression is likely repressed, and in differentiating heart cells, it's activated, suggesting that the correct answer could be D. However, the expression is low in ESCs, which makes \"decreases in embryonic cells\" a bit ambiguous. I think the best interpretation is that it decreases relative to higher levels in differentiating heart cells. So the answer likely states that expression increases in those cells.**Evaluating expression changes in options**\n\nOption D suggests that expression decreases in embryonic cells and slightly increases in differentiating heart cells, which implies low expression in embryonic cells and a slight increase elsewhere. But, I wonder, is this \"decrease\" relative to a baseline? Checking other options reveals B says decreases in both, F indicates no change, C suggests increases in embryonic stem cells but decreases in heart cells, and E claims increases in embryonic cells with unchanged heart cells. D could fit if interpreted as a decrease over time, but is that really what it means? Maybe the user is referencing multiple \"Braveheart genes,\" implying regulation by the Braveheart lncRNA.**Interpreting Braveheart gene expression**\n\nThe question asks what happens to Braveheart genes in embryonic stem cells (ESCs) and differentiating heart cells. It seems the term \"Braveheart genes\" might not be standard, but I could be looking at a graph showing high expression in ESCs that decreases during differentiation. \n\nOption B suggests decreases in both cell types, which feels improbable since Bvht expression actually increases during cardiac differentiation. Therefore, I think D is the best choice: it states expression decreases in embryonic cells and slightly increases in differentiating heart cells, which aligns with the idea that Braveheart-regulated genes are low in ESCs and upregulated during differentiation. So I'll go with D, providing a brief rationale for my selection.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "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",
                "id": "rs_08f6bd6433d5f015016909222401748195ade74c6635b12acc",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762206242,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1762,
        "prompt_tokens": 157,
        "total_tokens": 1919,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1728,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00356325,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 3.925e-05,
          "upstream_inference_completions_cost": 0.003524
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "What happens to the expression of the Braveheart genes in embryonic stem cells and differentiating heart cells?\n\nAnswer Choices:\nA. It increases in both cell types.\nB. It decreases in both cell types. \nC. It increases in embryonic stem cells and decreases in differentiating heart cells. \nD. It decreases in embryonic cells and slightly increases in differentiating heart cells. \nE. It increases in embryonic cells and is unchanged in differentiating heart cells. \nF. It does not change in both cell types"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762206242-KJH0nd1ulnssKATUKSmT",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"D. The Braveheart genes show decreased expression in embryonic cells but a slight increase during differentiation into heart cells.\",\"answer_letter\":\"D\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Considering Braveheart genes**\n\nI need to figure out what \"Braveheart genes\" means, and it seems it's likely referring to the lncRNA Braveheart (Bvht), which is involved in cardiac differentiation. \n\nThe question seems to connect Bvht's expression in embryonic stem cells and heart cells. Typically, Bvht is present in embryonic stem cells and is needed for heart cell differentiation, especially in mouse models. \n\nFrom a Nature paper, Bvht's expression decreases as cells differentiate, which suggests its role is more pronounced earlier during differentiation.**Analyzing Bvht expression**\n\nI need to clarify the expression pattern of Braveheart (Bvht) in embryonic stem cells (ESCs) during differentiation. Bvht shows high expression in ESCs but drops during differentiation to other lineages, like neural or non-cardiac types. \n\nHowever, in differentiating cardiac cells, Bvht is actually upregulated, which aligns with its role in cardiac differentiation. It seems that while it declines generally, it is specifically elevated in early cardiac progenitors, suggesting an important function in heart cell development.**Evaluating expression levels**\n\nIt seems like the question is asking about expression levels in a graph related to Braveheart genes. From my reasoning, expression might decrease in embryonic stem cells (ESCs) but slightly increase in differentiating heart cells. \n\nHowever, that's a bit confusing since ESCs are expected to have higher expression as pluripotent cells. Option D says it decreases in ESCs and slightly increases in heart cells, which feels off. So, I need to carefully consider the options to ensure I understand the correct expression pattern!**Determining lncRNA expression patterns**\n\nI'm trying to match the typical expression pattern for cardiac-specific genes. Usually, expression of such genes is low in embryonic stem cells (ESCs) and increases as they differentiate into cardiomyocytes. Option D suggests decreases in ESCs and slight increases in heart cells, which might indicate decreasing expression early in development. \n\nHowever, I remember from the Klattenhoff 2013 Cell paper that Bvht is actually predominantly expressed in ESCs and is required for cardiovascular lineage commitment. They likely showed this with RNA-seq or qRT-PCR data.**Evaluating Bvht expression**\n\nI believe Bvht expression is mainly found in the heart and increases during cardiac differentiation. From memory, Bvht expression peaks around day 5 during the differentiation of ESCs into cardiomyocytes through embryoid bodies, starting low in undifferentiated ESCs. \n\nSo, I should evaluate the answer options logically. Options indicating the same trend for both cell types may not fit, while option D \u2014 decreases in embryonic cells and slight increases in differentiating heart cells \u2014 seems plausible. I think I'll go with option D, as Bvht is downregulated during embryonic development but increased during differentiation.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Considering Braveheart genes**\n\nI need to figure out what \"Braveheart genes\" means, and it seems it's likely referring to the lncRNA Braveheart (Bvht), which is involved in cardiac differentiation. \n\nThe question seems to connect Bvht's expression in embryonic stem cells and heart cells. Typically, Bvht is present in embryonic stem cells and is needed for heart cell differentiation, especially in mouse models. \n\nFrom a Nature paper, Bvht's expression decreases as cells differentiate, which suggests its role is more pronounced earlier during differentiation.**Analyzing Bvht expression**\n\nI need to clarify the expression pattern of Braveheart (Bvht) in embryonic stem cells (ESCs) during differentiation. Bvht shows high expression in ESCs but drops during differentiation to other lineages, like neural or non-cardiac types. \n\nHowever, in differentiating cardiac cells, Bvht is actually upregulated, which aligns with its role in cardiac differentiation. It seems that while it declines generally, it is specifically elevated in early cardiac progenitors, suggesting an important function in heart cell development.**Evaluating expression levels**\n\nIt seems like the question is asking about expression levels in a graph related to Braveheart genes. From my reasoning, expression might decrease in embryonic stem cells (ESCs) but slightly increase in differentiating heart cells. \n\nHowever, that's a bit confusing since ESCs are expected to have higher expression as pluripotent cells. Option D says it decreases in ESCs and slightly increases in heart cells, which feels off. So, I need to carefully consider the options to ensure I understand the correct expression pattern!**Determining lncRNA expression patterns**\n\nI'm trying to match the typical expression pattern for cardiac-specific genes. Usually, expression of such genes is low in embryonic stem cells (ESCs) and increases as they differentiate into cardiomyocytes. Option D suggests decreases in ESCs and slight increases in heart cells, which might indicate decreasing expression early in development. \n\nHowever, I remember from the Klattenhoff 2013 Cell paper that Bvht is actually predominantly expressed in ESCs and is required for cardiovascular lineage commitment. They likely showed this with RNA-seq or qRT-PCR data.**Evaluating Bvht expression**\n\nI believe Bvht expression is mainly found in the heart and increases during cardiac differentiation. From memory, Bvht expression peaks around day 5 during the differentiation of ESCs into cardiomyocytes through embryoid bodies, starting low in undifferentiated ESCs. \n\nSo, I should evaluate the answer options logically. Options indicating the same trend for both cell types may not fit, while option D \u2014 decreases in embryonic cells and slight increases in differentiating heart cells \u2014 seems plausible. I think I'll go with option D, as Bvht is downregulated during embryonic development but increased during differentiation.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSI1_pRkM-BZlKciUEOwG6akUK7I4Q-rx5J3fbtbpuOR-dabMHc5H3L4tuM95I5jIKT2L3qGq95lKKxnp278FhdnkegSuFiJlgQ14wEkE7eyOXTag2INAJXrUCfIn0mblHSbyZhKkpJCX9t7fSh_SPZ4g3p3surXCQQmuXvCtLcQ0PiWp2tHC_iIQIC4tg3mC8UCI0TLP8gX9xoijQN6PGzxHWi1A_lEaH7F18ztOQ_ADze8Oc8g2ovAB_hgPVawfS7jXrPrsaz5hxkjqr-j-4BbyRNPKQ5WCgOvW_RhFK2kDAcRpyPB_RqsgxyUzCuZXoHXOqlYDv4LyWOgsh3yn1egs56DAuhc4r9dUeOZejUwWpFQ0qQTb3dqVUc_bxgC9Vyo8Elt7ZciED0vLK4iDyipsnU0LmftcVYBT_Bi8YOSnlUkiBtkRBJ-ZwYQlekc8gHj519V7vhWT9qhk3nGQY54gMxHfA1ug7qzk2y3rAXuAoZTRA6KYB5JC3Um73b5JYEtgq14zU3Y6SGlWaBfkCC2aM1TFS4nHAIW_KhMISE8BXDa5QPOpP1dUKiiiRLMUmoPnA-eV10aD6cKqroY269F4xyoANZ1m-355HeU0sOFm5wa5XhsbCA4x0N-4HON_X01tuCEZvIhlu4ioIQVgiDNM4Ui31UKuiKPUnMtHyx22K7AB8kNRFUqkzOCsRwyOLxkqxvmUWD9X4FnjWsKPG3aDQS2-28zp6SvoE437srmVrQuLJxSL9degue-jKSu_9LrFqD6gimC25bnCaeZP2x5zdK7Oso4yKZh-HcvkcKEE08r5MPRlu1MAvxyhs0oPeisES4wUPLO9EQ1_R3kEt9CRUwXYfftVfS890p9GTcRi-f6k9zXoIciKsXKtJVzuWulVFfsFephNTPZA8v5YNOZVo9iOZbfg3_zgP-Z-seReaflziW7J9McinYwGl1wRW0_n9lp41GxqrTmwQNnG3zR5Jmv5E7oweLBo7k2uCikTvToruBsOSlj1tYSL0PC3EDFNw9U8YgCp7WUxMPGmvl895OfQXqLqofcfft9TH98Hae3t04DDrbLZvgLuThGx15zpZ7QffI8-m8pgSq9M13uDoHJO6EsTsL7O4BP-wN7DaUsrWXFrhH9WhLBh6zM_JNk1tqxoWu8hZo0vRNAg9FuScncxmJj_eeqt_OfmQAnhFCE9JePBUSnb1TZMOoskQXJx2tMNzBOWS4BgxgGlTmrQSkBF0kbo1hGOHYBR4w6vd9ld9x4F8OWSE60E44mf0dbqV7xPznqfznHwhIh6ii37OakqJ4vvpGDjTlhkRYzdyTu_zki7GiS1_J5Ty8P0f0L5Evr3QswMhMObqZMXAzyY5YR5D7YdZOYjIceERYXxHEfSP65y3Cu6VgPAMaDUF-v8VWc58B_rbyPUy_TQedyJOpn89eYxROcX2q61NLRgqNML86Cz86TMn6ZhJFuFEOLIVmU9TQHsmhmM9QDWI3MCQHkCo2q4pHPyux12kVB-YVU5UuiajLnWx7vaCzkppKqf-2lAATn0XMzN4vq2inzvBh81pyrs5CSCQih75q6DTdhPQgPt2QpdemNyFDfkn4kCRA84jJx0wfWGPCukIahdqhH7oy0RjPIVJp3ORbPa0hi8vx_ePnXIfz0iAnms_lpzwxYi7vDFWzztksPIinh7fb6Hnlyrhgm2rMOir3_G3kOpTrdCXawy_e0kfVYnKD2sbYi3OtLZLR6y6IHNCJYyMMnytfwJU2oCo7Ig8zWwIYCu40AL9K3r7I6PJP5V5Vj-5i_uKIHZVTX5iyXSFQq_tUySGTJ9N1kUfbjENOosbRzwZ3AA8cBMi0mMXUF-33mxuJX5y_qeuYxRSSJMWyu5Y7xG845roRjdhHfRkIiQYfFHvEmmEoSJvId9MwJixptNH32AsJgLE5at5BHf0v-stDky1cY5WdPchqdoNTzv_WOzL3T9_dwFYk3wQfg9hITpfRBiOOYvUAnk3A76Um-a-e-eUlPFPGI5pISquylIF6SIgaP3X9Bms7XCD4st70ECkDb4WwNVaBAYzMiukPETQ1Gh--x2Z9UJA3sohRbt5-DS898Rd9tMHXPsG-kNOsbYuQ5o8wedVSF-5ot4xEfpFeVkJPA4JDqTPJ5t8FcFxM7OCGTMx5Q6HaZB7fRy01tXW6UNWD9mYWLlQDhW5Qapax_MO-hzvCs1CelqazvKI1nyEva7e_dJCTLBRZR7Uj5Mqvkh8Ps2reWqj3S4sCkD6RS4gTE2VFLBbHAydkE_rTg5poDy-BrtpIwR5UUXtP_wEqAdJmC4rVb8-hbTskQSewrXevdyiOwPeVXVGJxrlgO4B4O7-ZzVjixZlZfXR37x07x3HSxytFLHuejzQnsJl_rJbYpCW2Ycrget_rybgH7xkz63Y--n28TwCEVHt12ijLl_ZJRaXc8YLXBWC5oDOKYjmDQRnzb4Aiw4uswbBK_AW36-DKK9xSUnBW9u6-tooqXZUyENiqR3oPIKb8iZejZtpboViYyNF6A_l0sRUWP6GUZt7lgAYC1pESftXctWEQ9N0zeVsUTdmZPUfQ7A7hlyJt9Kz4FG7kkszDmWBg9L01I6Ws0hVzSQP6-WoWfvWqSJICniLdSduvsJhyiW_BPR4E_uw1PXWUtO7yC4JVSV5nAqMQyl-2MSAJlMa3a_e7XzsSRZtIt3iGxI3Up7LQ9FRs4FRyOtHkOw2Z5z8SeHSiAfS__CgiuwKEvSFXpRJgblgAeyndg8Jf3RlgiRjNkzHpXd3lBbR4fvFI5RxRJ2apaPxbviJeVFet3W_6WisQxYbP3y6mKsXizrHAQBuB8kpiH_uNDy08YixUj0G5l_IImFR8KoJxnd0Bm3lG3yMjrhRkMDHKId2l5w4ipUqxvg08a_TU-jp3Nt__8IKaFGdShM-4Mf7ALJ8QCWTfgMsVdaJHYn2m53GdYLSmpr__ctufZZ1BKXYSQJJt9MqdoWW1o0AmORmLlCPqr_lCBDjyXnuQAxAyawzprgRse_gnrolA1LEygCBhmWPiITiwMojeUFX8vIER91l2DhdTvVLOwKRoiGimPh2LcvdPjOM-KeV8gCCy7Ay9wpsJ87BUALjjOEeTo9dhQzIpGj3vIbVqMrwwz9y00iVTM1RSAMi6JB9ebJ7MohpXp6x2s3esXauF2MvWtqHLZGl32nbHn04hjW_23i2H_xmYLyOq9xtLsDL8nu4iMxenUr8WsCEX32OMOPl_BCYosFATXRrtJWdX9ESoXKIKd_O0pq9-uukmnKJaifTq8vuvCuLdDjhcjG1hNwM3tzpyco6iOrZSyaT8DClSy0Zj8ygd6DGyF8TmZG9uTbZp76Ovib-kHoufNry6bJQu-10ET3JWYq15w_oBLBv3UXubyqMrylbF2K7kGk8yiMuMPpURPri1hm8u0aP8XOohR-Yl8uUjFSYwAJT-7WIho9j3FuG0AxlqJVF9YUjKTvkXZ6HEAs91QgGxcfM0_DiSAYPf8kXtyJTinKtAmvpFO8fgSTv7VF8PM1cDIIHt1KlBVF0ZY0BrvhtJztvHwn8iHhTd_Wd3pXalVMx9tUbN8AeXFUN6kImgmITHpdydVijuROoMgzvrkKYn6uZRM8FgWhwlH9-c0N9057eN5MPlfZFwmuYqflyXFgIPw1yyuhdRQo-Dgl6ChBKoiO6XmAWjQa2duXz9CjIzdxnZ_4lKMsa7eJf9_nWNm3ziTE0z0PVP-AdUQ_cX_Q-UhsdlvrIRuM8e59wnWGGNcMwWzxc80BEHm75bfrKX9T76MG1p32dg_cx6xEOIiJ61bxLJImsgldNJcMsuvj4cNk1ZENihBAvHo8Abl2NLn3s-IX0PaaX7Z0zk0sIVIDeuI3_lIRo0Pf3I6dAZ14LpygY5414y5_J7YXkYTK1kmf8wwTljrnfLmK3aNzfJNvfLdweVoz2SoCs4dqDTV6Qfgy6z5fAQ-pN-laPMWRgfX7ju1DGdyFCaAGUbhzON3HB7xUilEmHFiMqpHZoo2mFxdm9NiHYZ27kagcwLqI8RHoAPrRPOLjB3KQu0Px3lt2IJ0TLp3ZYHf1HufLMA9Gd6VSOyVqp_CAN7zQUE2PYpxT-Qq1HHRpdx_zzO3M8Kq0-qB3qxSqUVsJlBy7VPgf6JEYyddupigDTioaZVbKCAsL6yV-aw70Ddw7l8epuwl1LQK-_AIabyksWzqujsJ_DeiLQJsF9m4VkY0vNsFVuVQnXX61N2ZhoFEoNhARAmJFZydTb-VG5c7hBErsSCadaxxX7_vs4xmwauxYkQblGc-NbXMb3xmjUCgvOJs2ncPlJn1n6luWf6K8VKBjknhYVxOCwgzLGV908q1iCIpKSHeZ3Q-XPg8DlUF2XoPoL44IO00pColLPX2kh6vu1P6oGDj9f7Z4CxDHcvSo_RCLjj7KCvT97omHcHJ5kEirkzqRMQNeeVamqF_ph1ReCUpnQbcIFLDMSi8sdbaYADvGQq3PIXjDMcFYjh8Gu0W1feVAYaTMYzT2Iz-GQi1L6ZTfeCyLlwZTnDohpm6d-KCI4YCEyW1xX1E8OHlkPQWU_cMTppDmLVKdNgv-RtJHftK8hOgnvQc7Eeluy_I_voHZi_Jy5g2q65wRBbGgB3OqlFfhoQ_KzD4lOqqr6SiGchnAtPedaQTBKefJpBWlE5-yLFWbvpwl_0YAwx7mVtdBjvMAnzOetpSqXOLNrgcsafqIafptWkZoOR8hCRCqfDBMQL9yWzur3VZhvpCawArGl37X_35I_Op5qFw1sJInbBbzWb-vbGgdRx6C0Y13ZF8ohcs1ZBFdGJJRxVagfnGViXpA7DdKRMqdmWlpapekKJtnuXco9n0B-q96ePhMhgrwd8UH6jAGVg4PaePJ-ld4I7t9VSPWQruDNpIlGzUTq4dV0H-EbIgcJd_QFfxxyAmV2wE0fUvuCyL8UJ-9BeIQyrQ3TgcYCjhHgwQWg7BCKxzTrm2bYmGhbUBcD-4YLyCcvJ0YwziubwbBHQzt0F6zLmyMJ1EZuyMI-WAsr36-fN3dWeNpr28HujzQVUWnJbmLluG_isBCdqjsyhkzZMp9RM-q43-n9pN8PH1N08Okbg0gDAbXVHOM2m3LRNYqa2UV0N8UxHEZGzYw8K4Vs0WIV9gdo1r_zEyyGqDG6BeazgNOq1yX_2nhYNTKt0gRe8y-wliic5mlRlxH1W-_xG69WuVeEiXG-nF1yCI96FsEorZ67VxewJ8VheTHw79af1vWbejCbvjgiEDzEJuLwaVMThGipkXRZl6SnHYHaDJ4ERSfgyR-rDyG04KnuUY3d7CywNmh-S1nMdLIIMzNUlPWCCmm4gmEwjs7UHc1Qto3Xm2Ypvs_fjDODlT3VwUvsrHcxFXNwUPBL-qvKvKkRrS-fm-_bTfXwtMtFPCQY_El32BmsNSU-MRAhtfrEiPqbN0KR0ZDB6odjvSBGza8AU-m1Z8LOWZOeUb-OHHU51DZWELjyZCrU2Zet2v6qui4W9b47RmJF9xzhYctJIp1ljnGi-1QdybzVe-8NK7WFiN77E4wBvlr1a-A9sl1I4GBKCs9jbDTxe0Ongq9VLqcvZkNb9Oti9Hi4sx3Q0wQwaHLluA6t3wRBGGF_DdhRiber9mW0wIbntvoXG-gr5QXelxABooXq__p0Hi0cPHuLsNYB6vKuO9v4n4mu7kTXzHrGQWRdDO6pbG6Vid_5b-bABoGOUXQkyGaV6VsOz2JvBbv8FvUT7U0kxOHgt0eywvAa6E8Msg11i2pEjgatmodP5y3RMYM2LgcnVDrF_Q5KmGHRoVHMfDZg5biExCUXQ1q-OwD2Pw36vgVOGorb1E4vkUfoYsryqomv0TOcEmje44kfN43m5tTpwWVqGWLgn6m9Ag-eYv8_iVoG41cO7qcbniFtNfiiKUhOw2N3K8kQmSEduGVuc-awC9RrcrWFoDM0CUqEHTBZgAWNKOzziCWGDE0Q91A6RCAZxSC9LNUf1DuPxah3R8RSPoWNh0cJkata0ldjbF7CZhGsEc5HhxmvQ6Nr4Njs4JR6DKVlbCgWxaezYjnz4nRqoryTXFppj80sjIwgISxYNi5mI8hO4tEgffYMFXWcQUi2NgOxOp5f-xBsdZWGj6YCz49Jbb-NDuwFtc18VEReVTy7FZY7RW7lxzsDFh_uYwiMC80egPb-CkG9_ILHRObS2P_bofjwcc5d60_ckIco0EpmyJyQxCz0EQhMUENPEm3MAMP8boaRu4ZweAZ3ToNjowgEnmxK7GB5YWogIYcw_TaA52ztGGJ9cTjhXdTXFb4mGpEldYemI6umxA7-bGOyf6qMu1NAc_U9onwzBZWDmEkO1fIKfO6qgRTAduQwFGi0awZdEIQ9ulhTaJfJKzG4j-sBSvpFtP7KRuYpShm3THZwuBbhYU3lDwjhu--gEJqm8qmIWw18gZ7VWJZyK6Cj4UqIuq1lfgnB5qhi4EjyC6MMYWFh60CMh5pPi2v6-4arwKEvlBngOsKuMEdF7I1uGAMzPYNpfgjAdMXu8Qrbgeqi7oUSiFHullCPpYxeGW8wMadU4bKv8gK_34bnhN4diHRqByFghkcWUTWasq0p9a27C7E10GzRtfphMGb6006aMEEQaOZufDW_2u5_11hDkWPxYOjX8dXxrupOPD4xzhLr19hqvup9qVrArG9MXCFFqKOmxZwOtcoB5PSNqe-KYe2Y4Y0grDdPWQb9OBD020qLuCz9iCWbukHXeXrRy1TzRo1o8Id_h_zdHa_egIcAWpH6WslvcVaZojLT70vavvbT-jGBA02Z6v6FFL69klb369M00G9oJ8j96P9y6wUauwT3sIUfCzTAtmUV4MGKKWhOHWhgvZy5sfe1LslCwn9rZHIOtEfIbFCys7SPVSPG0KVm40-ssJo7sh9cFqW7DBnfcA6mSizllE4o8iV_LOgNVebuiWQydHBBthwjkAaN5clV4SF4_RNgiRAUzMNxO4uKZAA_nKteen7wLD2f0uU9kx31JfRbMdDZPPE3C2nD2eDEaxGMFj1FaclFsUR4EXmdlGS7bS1woa3yT8aOYZgvYLdeRDrEL7gr92BVh2iXPYbY-4itvwbDje71Peq2IO362Wh3S38v1v40FPwS7SJd7vOWQjDdDkcLK2_0cXLMLSnQLw-KHCjob8ouIEAznbSRRAOG5qmgCGQ05DwG2MltxOn3ibchIv1i0MQAX5yrCgD-4dchXaUcZHg_-Mp6kpzLt_T0FVI86HG6WZzQhhjKbgLMS18ytpN2_YEZNEa6crMvO1aPrWQi_GL2DdDfNJDKGbPylfLrzUMc1Dz2p5Adx0Wa8Aerf6HUuapo6kXlty-IdLXqmBu4Cvs45QkO_m-n7CzweesSvTnHnPXSawqsxNnOQg3VaJpXstRDy_nIpXdpsOBil7NX0GNtudvE5gMCFfc8vOi4dPTzwwdZRS0QNTo4emNVxxk7Xb1upglr6AFOmoicb6c4NeHR59UtJ1R0EHelJ64C1OgHUu1Plio2GzKmmGIB1OcVw3FSMLG5rRojWFKFlErpDlTOXe7TSmG8TKqGRM9t2c7P-2lwVaZcPgqIhhSQ5CBZ8y4r0oMbY67RRUwXothBOS2DHfQRzPdkblIXFYGgYsQ4T19jDocEd5lnLPBi4AmQopvAY-iezKt1_Syjm2CRlmY3txKc-K7a6UiXO2OCweVg3TzJuPzqvQUnaF7RveqUZtQK87XKr3BDZj-hv_WnA4hpTSqRqMzaDw-wog8rPxzzlaKwOgAWTUkvgu2Bd84vv9yivL3aAdD6iHtWA-rkH4nOUkbu1bx4YltceIcAnOhwM3Sht0ccTxUP2wjh4Bgb5lL6WAo5nqHZ_XCwZd3SCrRL8-oTNpzMRyfwwZeuvCJ5fMP0oMjW9FqAcNUzO9DONSExgDcvCEo8b-i4PKFfaUmKcJFn0Tt4txIWkMfkMkeTEgofU=",
                "id": "rs_05071e8737f594ed016909222350348194beb0950783b928a0",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762206242,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1064,
        "prompt_tokens": 157,
        "total_tokens": 1221,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1024,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00216725,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 3.925e-05,
          "upstream_inference_completions_cost": 0.002128
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "What happens to the expression of the Braveheart genes in embryonic stem cells and differentiating heart cells?\n\nAnswer Choices:\nA. It increases in both cell types.\nB. It decreases in both cell types. \nC. It increases in embryonic stem cells and decreases in differentiating heart cells. \nD. It decreases in embryonic cells and slightly increases in differentiating heart cells. \nE. It increases in embryonic cells and is unchanged in differentiating heart cells. \nF. It does not change in both cell types"
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762206242-o31H0vSHT2DtGgXLnD3L",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"The Braveheart (Bvht) lncRNA is highly expressed in embryonic stem cells and its expression decreases as cells differentiate into heart (cardiac) cells.\",\"answer_letter\":\"C\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Exploring Braveheart genes**\n\nI need to clarify what\u2019s meant by \"Braveheart genes,\" likely referring to \"Braveheart\" lncRNA. There's a relevant paper discussing Braveheart (Bvht), which is essential for cardiovascular lineage commitment in mouse embryonic stem cells. The user's question seems focused on how Braveheart gene expression changes in these stem cells versus differentiating heart cells. From my recall, Bvht is initially expressed in embryonic stem cells but may be downregulated during differentiation\u2014there\u2019s a lot to unpack here!**Investigating Braveheart expression**\n\nI\u2019m looking into Braveheart (Bvht), a 590-nt nuclear lncRNA, known to be expressed in cardiac cells and embryonic stem cells. The research points out that Bvht is enriched in mouse fetal hearts and in differentiating cardiomyocytes, but it\u2019s low in adult tissues, highlighting its role in cardiovascular lineage commitment.\n\nIt seems Braveheart expression likely increases as embryonic stem cells differentiate into cardiomyocytes. Now, I need to match that understanding with the provided answer choices to clarify its expression pattern!**Analyzing Braveheart expression changes**\n\nI suspect Braveheart expression is low in embryonic stem cells (ESCs) and then increases during cardiac differentiation. The answer choice D suggests it decreases in embryonic cells and slightly increases in differentiating heart cells, but I'm unsure what \"embryonic cells\" refers to\u2014are they talking about ESCs? The question specifically asks about changes in expression in both ESCs and differentiating heart cells. I\u2019m recalling that Bvht expression is high in ESCs but decreases during differentiation. It\u2019s a bit contradictory! I\u2019ll reason through it and keep in mind that Braveheart activates a cardiac gene regulatory network potentially before mesoderm commitment.**Clarifying Braveheart's role in differentiation**\n\nI remember that knocking down Braveheart in embryonic stem cells prevents cardiac differentiation. So, Bvht must be essential in these cells to kickstart the cardiogenic transcriptional network. It seems like Bvht expression is high in ESCs and maybe decreases as they differentiate into beating cardiomyocytes\u2014likely because it\u2019s needed earlier in the process. This suggests expression decreases in differentiating heart cells compared to ESCs, aligning with answer C about expression changes. However, the question's wording is a bit ambiguous regarding what \"increases\" means here.**Deciding on Braveheart's expression**\n\nI\u2019ve settled on answer C: that Braveheart expression increases in embryonic stem cells and decreases in differentiating heart cells. The phrase \u201cincreases in embryonic stem cells\u201d does raise questions\u2014compared to adult tissues? Checking answer D suggests decreases in embryonic cells, hinting it might be low in ESCs, which seems plausible but doesn't match the actual data. Klattenhoff\u2019s results show Bvht as highly expressed in both fetal heart and ESCs. It\u2019s clear it needs to be present to promote cardiac differentiation, which supports my choice of C!",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Exploring Braveheart genes**\n\nI need to clarify what\u2019s meant by \"Braveheart genes,\" likely referring to \"Braveheart\" lncRNA. There's a relevant paper discussing Braveheart (Bvht), which is essential for cardiovascular lineage commitment in mouse embryonic stem cells. The user's question seems focused on how Braveheart gene expression changes in these stem cells versus differentiating heart cells. From my recall, Bvht is initially expressed in embryonic stem cells but may be downregulated during differentiation\u2014there\u2019s a lot to unpack here!**Investigating Braveheart expression**\n\nI\u2019m looking into Braveheart (Bvht), a 590-nt nuclear lncRNA, known to be expressed in cardiac cells and embryonic stem cells. The research points out that Bvht is enriched in mouse fetal hearts and in differentiating cardiomyocytes, but it\u2019s low in adult tissues, highlighting its role in cardiovascular lineage commitment.\n\nIt seems Braveheart expression likely increases as embryonic stem cells differentiate into cardiomyocytes. Now, I need to match that understanding with the provided answer choices to clarify its expression pattern!**Analyzing Braveheart expression changes**\n\nI suspect Braveheart expression is low in embryonic stem cells (ESCs) and then increases during cardiac differentiation. The answer choice D suggests it decreases in embryonic cells and slightly increases in differentiating heart cells, but I'm unsure what \"embryonic cells\" refers to\u2014are they talking about ESCs? The question specifically asks about changes in expression in both ESCs and differentiating heart cells. I\u2019m recalling that Bvht expression is high in ESCs but decreases during differentiation. It\u2019s a bit contradictory! I\u2019ll reason through it and keep in mind that Braveheart activates a cardiac gene regulatory network potentially before mesoderm commitment.**Clarifying Braveheart's role in differentiation**\n\nI remember that knocking down Braveheart in embryonic stem cells prevents cardiac differentiation. So, Bvht must be essential in these cells to kickstart the cardiogenic transcriptional network. It seems like Bvht expression is high in ESCs and maybe decreases as they differentiate into beating cardiomyocytes\u2014likely because it\u2019s needed earlier in the process. This suggests expression decreases in differentiating heart cells compared to ESCs, aligning with answer C about expression changes. However, the question's wording is a bit ambiguous regarding what \"increases\" means here.**Deciding on Braveheart's expression**\n\nI\u2019ve settled on answer C: that Braveheart expression increases in embryonic stem cells and decreases in differentiating heart cells. The phrase \u201cincreases in embryonic stem cells\u201d does raise questions\u2014compared to adult tissues? Checking answer D suggests decreases in embryonic cells, hinting it might be low in ESCs, which seems plausible but doesn't match the actual data. Klattenhoff\u2019s results show Bvht as highly expressed in both fetal heart and ESCs. It\u2019s clear it needs to be present to promote cardiac differentiation, which supports my choice of C!",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "gAAAAABpCSI73y1hnV-cLedJyR3s1JA1u_7NWuHWy1t83ejgxTMp-8tfbbxCTSZd68t9MFVp256obUphqquzx4uaS_jG1miT4U3sVrCnS7AoHc3gTu6cdR9MOB0Z1fFLPCeq08xblMsOepu4OgoksiNxNzs-AjWvamy1MRV11jXebre6Np9XMBJmFupjqUAwe7G8I4qiDa43Jpk934s9K1YMuequ9_2ZeJ1M8gIzH0FNRHpJNQC0fbhkhFgkMWBtryCwojs3el6iD93RXPPVVuB2uNudN4KJpBgm4yzpFIYnVD_GTIRkiiIzb0C0YONWFjA5YX0F0XXlc45jRZ2uTObxhPo5q6oBrLpIZaTIxdFqZxG1lKdjST-FxTzlG4rAHcOtqyUNuDhpDVISWMVKNZlmJBtyw8nkR-uNl809mACL8h7E4vdhGwDc5Iut6J9HNC8lIuaJKMWdbPKsGyvgf9sn-PCcatEbwZD2-l2peXPfS64QuiUTYsBcJqLvTGtfG5FFJyxBLe0Tz7UlNlc29X7wjnJ3UUUhnEjoC2Q8Pwsv7_gfO-wJhKw4FKHahFJo9nLmhVzzLZIgrd2fd8zQUhGoL80wZRTTEKGwj_VGxHSqM6vgRiOdwGW2cUhZAIt70PY0JlbzMexEqN5diLlFKT5u8yA4lt_-HzIABdh-yPRHi0pWpOMpFhgRB1N53SGIYZGJ6FrbkiL0qCS-n3x-pBztARySYf_jV_gbl7bw01vqt-4_pfZ5c_qI6lfBjqd4govahnPfKoercYgdhfimFxFdaFPAu2ARpM3Vl_uG6xd0iS_XmmDX_TuB90Bfrsikyt4HbF-TquEhfNcgqdEh6WYo-uCM0fd3ErMtr3257wT-USH2XVfdt-Dsj3u2vmvJo7j0hWuko2uBjnMDZUbaRmPk8qz_qbWnrkKffz4wYaI-gC9lSyd_ibw9U3Ya8v_btQ7tlaSMN1loE1gY7qZHp-uIjyBRmAKqXoR6FDrkrQgGk5WhxRNSfbZuOezumPtJEjxoPwRcXRoYgXH66wMDRQI-JOxFYCjNgdAoajTtCBrINPkQsRyBre_C1Nni25M2koI5-kYzWH_APJe-zvZWhn2h9UcPme9lGpPyMvTGY12Qkz_40ipjpPbOZn5-YZSbNnPYd2_usMCA5IsZJgfp_TiOrBarOyE4Q0JEKXRFuLLar4ghYH_NmrJm20e8YkxQMvZKfsXZWUBlJtvHZq0PiXm1CrwsNSXAA9QWAp6sfk5HzXUQFJbedLRkMt2tI0kVj4PacxYaacnCyTJwyilRbcQbaiqeWWfGOcn8ej7CogB101-5QS-d_jGSxoOdRXdUQY66BcoCDSNODGKXsB8stSmV6OhK1I4anjW822F-g_m4BZruHsf2NrNfX1C-umn3IWd_VgmqM6266USikhg0oDw3U6KqVccgkhIKyOeJhG8vORtSx88GknqA0h7yVn6d_P5ozyfkKqU2Ssvo6keBhnMFlBRxWTBL2UXa3NTzSqtQLm-IR4HWU5zXvf0XukyeZTN2NTQ6OG-vCc8TEagmhp6P7-GvmuATd12But7JBvQQedxpPZ__S8Jaigcl-j8CmOS_Kq2Q7gU10EQGJ5amu8CO7MFWaUmhJeF0R78109qyxDZVM7mCFlxvmU4A0l4kNRXEqemXW6fLi6IQSoGwHSQMhu1zCAjsJVYacd7-zjsd-FFNWJOBz6o-NfB7pAv8NL2lhXDTRzWNVRA2__DN--R8nlzg5TLuIQSprmh2mbC4zxl4ON-GCFES3enBfVaRaW762ZlWTQqFNOOmy4gycmg1FQ6Km_RgcHVj_9vkLlJSpaS3R5UkqZUiZbU3__nrdpl59zyxKFV56SUrg6R17K_xNh1pcwjKppu2koACW5XvVuq31VsZRdazZF2Ykd_c1noGcZJEq_TPZh6DDrMEzqDXpNV3chm1SvPcY-0EKkYM207zpSZNxcKSvVt0PyRUwn9LXvmO1cL15kZn4RQjaJ7wEUy7bUWca0qtd5jQBHXKehxRSUqbAj1j9MWCQDywy1bXnayOTwoe-kf0Txd2DURTZXh1PWvDYBfO4-ljK81-JiYfNyEWk-qQDci8iqcdGxF9LUA_2yskMSBRBw8Qf7YzTx32iHE811rM4CDDVfGG1ItZpp7z5HB_jiFBveRZevCUE_yfHndNnhDELWyoo4fRqROZmVC8GOzM2NieLO8jbZU_U_u2ScWGENG8FeYP--Z6bVmlhZqHnJsp5uF_JpcTEDC8t-j1qMWBhm-DNOZVKkO4K_II4laMMCM2PfkVRmEl_28vNR5PvVPL92S3ePrmIEz4SCGPJSaGfynRkkrMklFqTJIwPpJe5gTtpFdEjs8VasEvKHWatWMP3XmtqKZaB3porNWtbt_ACjx15sBH6Bg-ITnKVFdmDdJCcUItJK4fKS539ZvgUDc9IMrVg9AqMnWsS8s-LIPShWMVD4VyPJdWZDeUYjCHNLCYuyeKWP6GQIQJvFbcPMbzQSL5oBvJZGd0PQpveBCR11Zg2APd7kr8dBhs1W7Z_wYgo7Zdyn2nCTJj7Rm8eIvE_EGNF7Y37wMdZUvM5SJqHartYrFU-2JMv_an9fkLbWTkRTWCDVuRLkaB36sqZSYqE6BZANp9MVbzNE7F6unAaQ7sRODpyiq3IwmaICaOTMdZMDWQ6RIuI9tCo_KMmlFjdbS3JJMjDMYkUqBolHgLApTJsteCPkd-T0DjDOBm-p3ALZMx-aEiT14LaYCYaDiLPn0648c-jRyyMz1C91SdQhC4i4etJbngimVQzybgpOz3id9w1PEgjAOXv2w0oLW11K2a_k9lPyfbodI3ig5OWgmEph9SBsZ06ccs1LLzkyo23bny7ubivwKakPdo_4pjRlURJY0KgRuDMwrGbo0ehzi7ZguNP2FlMOZP1BMndIzfS30KnzL6cPZn3vHfNcoka3_WsCMI6HRSDHc8ktiubqK46XbErlQnUVL7dbMKiHAF-NJo5Xg5YlmJcDvVB5MqXn0z2nERH-kiRj6Mfls2VIdszSdHcC3PshnJgDw2xveezTj4qK_FrjDafso5HqDorGQ-2ndVRXItx0AGFvcANVumjdI5PAMeQVj-iYyl8ovW5SUzHXY3XgVLNRj5_rW88gwG3mWZ4lOMqypCuPUiYwLZsZg3nRv6Qp26upg_G68gYBjJtivjwp03nF0uvE6BLYytRHl_x61S5_gThwRKGk8BX7DBe7bIrklUWRulkk_OQYpcpNcxd9vPxRFXFL4YY_DwVlwje2y1V0xqpXO9t2xs7P9thKtoh5VWUrIPrK8JIprjVa5t75FEA4jn7Iq8yHZuxQfASBCzmggRy0FnFV_RNIHNNfHS4t9iZ96rJ_xvgeABL7ZK_FMCQBPUseQEGuAVO8brDK-SHe7Nq-BzyJ13GJamRnuz3fL4Z06tkdS-7RxuxJgrJRsHNp6S83qG6J7IBh2pSCXQBcIBuMS60LTITpQDv32UFk7LJaRxQvx635C1v-K6a3oTd-dKkVqcInSBSNDNFEIpfjbpEpCbipT0bqCCCaTUAcWTqQhewYrzvBUeGLWFbmlzNUa-P4FGdNOOYRNDe6c-0kvA7xr9Yjs6B3zlVL5kSubtvZa9NHcbaPVOCnI8RwyOEmZVV3yZZqh6dzYQzLQcOW_Cv_aeQtqhmnOIx8CkcVMyhxpFDgNJwDqxoBGbGH7V_ex3vHSwiRRteneCnvovysZ2XGtGAZ4JeAl6Gzrb2ARqw0q9R8JWqz6yxlFlg3MKhDtNBv_TqeO5J7epJcMMwHu15bKJbT1-NyJyhZTaeo6X3OqztbHYAmbyJBZkLU2r4VFpkP4Rc3NdYAfJCgannWRUe-XYitVKl1XQV86wK-W2JiUd--xJEcRulj_KLGtieKbw8Zti05iS-nN2WIZs7DBO7uP2cRwD_JBPG7JSdAc2WIzqSephOn7WCKiQlvL4QNdMLYRE4PGT9cu5ODhNEQvCexmK1_Noq4R26cJqKlHTPHolr0RKLWz9RnDu8Bp4JfqvHr_zHFMIQHsyRVnjnqXU3iO7TzKUzZJ7EOtwvMek0x20rHeMt1oQQM8YiKTNMtY_AcJ6EJQWc6Kh3rZC25AbpcsT144mDzDkjn0sLWR2sy5-qsW4bOTspp0tf3pvvAeB1yDUDb4KJchb8xsUscdSB8Pc9hDWfo7SHCCddkwl06g91arbOZH-W6rnXG1O_9ocYlXc9n1j0zKOevaibXPg1SaZRTZ2dYsIXQHf_wY4eLoOQRzwFV55EyWy1oVwmOmi2aAraLPxnPmpHojfxMZhNACmA0d_5GPDn3nbx7UcsFMwRbjIpSO1mwwBjltRaiR7uGezbNYC4HQ0LYo9BjcbBwtRoX14JtaHLfHWusblNvgCzgD9Jl86dVbRlPgeX76DtO0Ir5V1-_u1bHqkpefriXV7bQzbIPXxP3FNp0i5pVC6jdmIrQ_Xx3Se2U9E8ZwbluINFzuOuf86L2baxCZvi4OQwssAwEwRqI8H2O2s5PZGF6WjTr6CYNWo7KfLJo4wyOBqiSbdr-4rTEsTCaGXy0ljdW9V_bhulc8o6Av7eNfK0p0WglqiZPTOQxBmKyXqx1mDS8zQywOGRtJ-donATmgwAJ_rCBkyHaTIlrfnCNCy5z833tBb57DI47ujOqCg3y98Xcr0zkD9axWh7m4tMn8O5br0gDIoeEA1Z0gKiRhRnu3yF6tJSox5qKQCujJxGOrBuCfsdzFt0ol3RCdZleEegjIPK86uy3uKDT7C62GCFHq7lRg_MIWcIpStxPHFb0bPlVudeJHSzKDQf-pvzSPY9SyJF7NZE6Vs-NJH1B7lQT2FPcWok8J3XaZaJyW_bqR33tt4BCnF8r2Uuhf2bwRHBAcCc1wEnYN8mQQDYp-qkR3mxAiS_ltQkOgsLj8x2iaAxsGButITr0S2v3AlsvJVYeQBs1OgBsuU4bi61TE3YvX-IW4FUzDo6ndaO5ATl1_IDwng4q4JFa1x0fESpJz_X8NwfNNnzMzlhB4nWUe0p73NJoRhwS_LxTRjwrjWcnmWp4UNp6JDXa0w7V3d3m-fNaDz9pGSZqjyErPMzskua2IZ-frtm5rQs3t5Z2nlA66m_u55k45Z6On2h7fr_Urt577oUd5KrPl9T5uYkRXK9bNLubUzL4tr1hdPDSoZaFLR91rmmMD_TgkeomNuuNQE2DFGGuMS81OfwTUtQVL9Hc7qInZbaR6NdFRWsBlX2eK9FQyDU5vlvQe6OalfcldDUHioe8F1rUJggIdBfZ-Gd5gSPO8MLPQ5C9lTNCbFyxGyGKkRr4o9dNNPQtEwC_9Htnz_d95p3OgTf69OUQPZzXhIJbK3WYKxtCrTS0oP9Favd1Mlo4RJ0rWhfluX1bVKjQnwFakZuaYtthVLNe-oy63uUYwPyCbfl7P1F8woQwsP5WiHuSU7VktJlFFC6sa52aoydmzXbK9eMBEIAfyxmkVALJY4JyTqYT3OXUnHO6zojSO57mlBJDrxP9Fbr4n3xgTGyQNQvJSJOl0a88CDOV0YV7UpJJ4QC7t3-viRPhpIWhuKinoONNmoYxQ6iwprkdR0MnlAZgZLanfQNqDNwuViMVIF3HnkXRJjSJHFRGeDcqj-8paw6OuAXwiV3jVeyIpyNBJ7eJHDlqmMM1MmQHM28BLnFZm0IEFjAcAI4ugfQObXaIDf_jnM3Wr-RZHj-7x_2U2PODKRCw21AUHt1UIOntpfomslP9xgXoekC32WvY5wvbUyL4W6H3IcDXmLRnsym7dlBi6wd6Po9pMOQSrN7BaWbBIegNY69BmNzxzlf8uT2q5fBHGM9prgJGXjn1p8wQiboDEAsAlE-8XEYY7AZVXxTGxctW01BSnIBKvZx0RNH5RSS0b1jx0lGdAaJrFr0LsDJAoGa-RR2G3IT2yU2l5NNvcxn4D1bSAiwMHgiCbT1_f2k3YNvDF3CB470Keqfpj_o9tjWS3eaKvMhqiCn8bozLFBEoE2huyefsLXVwYZWCncCfy7FspxahVfabtdeDHsgd7CmRJoywZFgSaU6Q7Wr2Rd6mqKUS7GykkLNOABo2j0yBI2bxPDglvPHwjn_W9rd1kqOQT4ivi9k9hJmuewiimEZ2jtnRlunj9vlv9Xbwqa2A0DGqO5C4dnUJ4yZCBXv3k9-TJMaUG96jd25oqucU3KdVOXIrLpLX0v3c2YJKGFlSeLowvIV9-TubmJfp2b7L7fJ7ZGJIkuhMN1x93qggsH3o6vCLGnbuf-_BIwzUEV5Rqjw9MFa-oDDQeGnTDGIpxgbXThzRrVSjexYFAe8MwdqirVJv4D2EKROr6QaGTOLsNMrLfZvf1Ujh7GkX3Un_IMPCCiRViXFoNnYpG9UwrlR_adQyixWoPhyzeFV2Pg3x8RLZ56AkErMBLEW30F8grvCKhGDgBT_O9vTCw-8F7pSy0_-f4VsISDB6G45e1jspnnVMosAS-SSZDHfL4cAEBl5xxQoBSLYZL0BWQvfW-EDycIg0cCBAGGclI7Wu5BmYwvorTtilquXxj_YdCN4eYzRIlPRgtTp_c17UX-9M_lDnG5lHxPeL1GeieQcchqgYSwu7Bk8Wv3fKzMFDianlIZ5RgfgJPYca0YscgsH_a_x7bRDM5VRN5OmL5gbhR_kS-xQqxmsbLCaVvQiQVj5GqM9xcQoRkLn9lzCWegjyc8WvmSVCElpyFAiAU0u0LCO3QBLNkz7HkyCs2SwcoblQgxEfjuycpkXl_zOT3mgrHFpBBhZqKGLcOfoGZ1rqFve823lkSAmvvd011GuKBLD7jag8pvJLNKfA1gL1F4BfEBZ7lU391OrVL1Q1f6DM-I4uLOR7fBCAUZYVebdGXU2bqmSK7xaJXBBC2mOPfGRUr3hoY7N8sieBZu-Wp-uJB_6P5PAE2jdAAB8Gx8C8p9R7XreciAHsW12sbrMnXuyBg5vC7Sz6zf8U0l9Ofb6j7ML0CJ4PeHC02vEK6bsFBJk8fFtBXLlLgDAwTN-Maip9Q06y50oETPHgMTKDdNFeeXX0n5AbkJthj2YygQ-5fl_J-ppfe-2TDaxRgB5z5PW0tPFpOrKmukqRVROim6QPj7_joOL1fSinBKmzTxk42Y63KjBW-wSfdP2N0_WnDI-fiCwmYFtnAhovuFAujo4RENYMzia30hwmmbKagKZQCOSLY95hDni23XpHAQU0PryOZas3lcjKut9lE4XBDNRrd5NOXirY9LOEHfs0oMKciDdqsjrWUEkF-5xa0NAfdBrD-AoraxhlFojhSVvmOUQwRNYuT4Z0ns-Wf5OQV4QQlb1osbciGdy6Ir1OZYw9a7qC8oqHWh_UXTVoS7gUBq5D8kxKOVdnBY0CJbQ21HqX5RfKKIbG5i7WMWjPzAu4KRthcp8wokBE1-3CrKHdT-i_v2mKv7hKwCM51r1gI7QpIyVAeY_oTSDRowuMcXgNWN3jU6nD1x9SvDMW22kbKTxMi-ajvBui5yZKD--z4xnqbMs8eat0493nW_jMPv10FYet00WfQgr0DJ2C1yJT9ILVMt2EnPJRQuWa0zOYcYduf5su2XAWB3AwJlCBofjG0awix1P3qCu1yCDuhHVhyx7K1oYfXQ5VOUjbmEp6qTsMie6ri1deh3SwYPfMWMbe-0xaHFmXwvVcf7CTfWAqp7XEHcZR9SAITgHtbq34G4nXza_b8Sth-Kv3b-bNcWmiu1oCFdTk7L47DwBG5VPHndUFWf3SBAmgGgKILE6sXyX64TEzxN5kDJlkOO6s_-EKzfpU37LLrvoM4dBVB_o3oI-QkM6uBSqJLrm1CczQ_AIFhi6aMMRF6NS8uZrRTdYNHRPJhGJ8Ud4A843y8gYKMg-h5q72uwabqHmySE3m5Qyj0HhOPkk_Ww1ZmYkbMUlbDzJN32qOJYWhoAuJCr1OVj6XgZi-R28nePdnfvIugDLd6wKhTeh9ySPpKJxJueX15A18W3bYmHnaBf0bbZwjKH0OYT_eBhMr5CPewivW7nXtKsvZ0suzu_qqapVoJGNuVmaHedTkxmP-tolL8vo2d9KZfD8IVVjp8k9o8vtkuU6SDm6t7NETmB61c8DFLZLqALecGoCv9_vC9lpFa3kbtivrbTJsHyHhQrMcCpttjZ-snv0TObkx9_TY3nvKhtfWoAkxkt3LsxUo2xx5xZtaWM7pcFDj_UWxERA5NVrUZnR_EXkuZpwBQzba8MiOLk8yGTCFT4ohutg2jMS0z2sHmO3LY3qix8Qr4Qu3HyQ2IsXlKv1cxZ1BBWMpq8WhU_N6NWlFNEYmtKTAKqYFZkBD6tOUSqpRARga_6njY47srE93ChJR_bfu-DBRCO1G9XaVQ5ifS8LTPpSAI1x_eyUXfXdok6AgQ7oQTsjSgSDSpKU7ELkfSnY5RMve248qFsz6kj52uwMxg4oc10MBfyfnnoxj5-ULVGcIhkNE2zSXeSPJL6ewpgrhtc8cWTRBC_JvEzSdHtkejxnDYz2vz2jo1y0aeXOs-gMMsYmFbKvcqo9oG0wcwrDxmUm6Gg_gmRhyPj_B6Qv8DCVIHkfTxJzsMzEvV1p7j246dULWy4KgrLScT3IH8A-H258rAEPHa7xDJd0nu2x4pJm6mZZ0Zz_Cwmo-HOivyjYZehRqc2qPUWjkRBHUetVrYcPqtEjdpian80rHh-fBWfRSEQdKWP58YVJtq36RIeB3Ir2HuMKn3894puk4X8GICxgLvmovl1guyEsJSF28a5wgbY1AOacrM2PCRCbTRdkJJMIEqNV5LR0ihqLEbjxOsQQ3A7v_SEapIdQV8wE4rRw0XePboFHCS5lt00vvYsvzA1eap6JSRuu8B9OLBB9GNdANrBaOVUrx_Ow0K2PQ2msloMKwnc-OX8QR2OtqNOhJMulprBgdqbT_vSk7LamWz2VA1sATZDuHf09a5vJhJ8IqbjfWUlSog9qKkzPpOcydta1p2HcwJYLyWc6tMLl1IeQ6gOBmJqbeE9y4gr5Q_5F0YKf3X9J5xU17Ll1DxfTQHhL_oYiAf-Av0nBziwATDBstuYus6tkefCNmGCuR3Ra0lqNNA2ilXJz4nRuvX5VOfEJyI3G9xFqAJEvyuGiqNyqNcQaRc9WXXkDYNvDdFOr5ilms1QbD8Yg_yjYjjGKbSR2ONtuiTROvGyqQqXPFFtpu11iK-iROuRZ-AWVndcwPh6n0z-QXCzw8Ttn-0TqVRV4uOLrGcHUc1mVBCthsrro27XgLwtSKl47I4MJqD9vjIzBQtPdfM_mCcChX-MkA-GsSKF3W620kvwG6Gqm_8PCXUZUr8zHRWXEv6DrLulTNqiRCftEjwHvu075DP6vDuvmibXXMnuzL9Ig_cF0RqN5M8aWCKSwBa2ix4QfFH38dSIut57UgXeEYtr3ta5zgznk9J_zl60z-gZv7HX7me3SQacURJ_a80vdf27W0Zyw_1g8XWw5H19TqJ3QpPatjSddp_amS7DdJPXGeiCYnS7lC1a3YBSid_ijrWPN133cBwXfOO-LbLUIKz13SLtr0ep8B4Dq06wheH4vHWlEyKmJrveJBJCO0vLNb4Hdb-mvz0HPLRlZRljkiGvX4Skb9zz3kppy_ExRpguh6mWKvgwoPH1IKeYmAPYj6wOfyY8GNhlg8dwVajkDUFQSz80_sPTloMyixEBvnR7_3XKR-5FRAVOwobQkN2SR-NblTKVOXL5bN7TJRBJJv3MTcWMJWSXSBEaHbwQVxkoFWvCzk7U9DHiCc-8H8nG9_9meQnKAm_rh-m2DcDkQ5YY2IPs1w7kSIa2qyRcKnS0fN1lgAiUtZBNOPVvgAhav-KauCv_0TI5VN3SRN0uTKhzWXiYvfr3oOBwU3dYVJee6Nbb474krd9oKI-CZmJvhHNIR0vsmrhih5Q7KRR1bw10o1N3rJhes5hp6A7U2DlL2HgFxE9T1h4Q_9LlyW-0EeZGCT26Zbvlq8k_-fcEOFNjDDW_3UKMRRlSXmcKHQ-J0fBDCRhcJwkc8ivC0rB6BwwVQUu38mhEMQhXZux2iCc2jzSWyF-8FyypEMNlPs58nGFjQe3jabTNndU53k4-xsEXRaNlNieNWAAGkMd81r5N57ULlsAWk43PYwym6-PGJrPWZ0Whb9nk-mT350aPAYLjY9XnrsQGhRzkhMlBJBNdYUei2-yZJk2C5XjJYzcuP2LlavSpUF09MjlMLLPZ0pRLBWkoRJF5J-jchMkDuR6eXCj14CJWarYdf1Yjys8V7zH81fPHH7OIrQWGoherzwffxobpAqIYQx5_9NNt9prhYVn10Mfj5NTkEuUOEJ_gh6Qp26TFRivVjW5JCt_w1a7GQ0Ux6HRcAVD81M7CK244TPyKd-lbbf8zlSqQhbKfkug51FREHU4Mld8GLa1oiTsxv7diJkYf8FfHEyg7hgaaxfSVt6IkOkFGZXU87-yFsg2RAoQUkMcsn_QzM2PbaTljMREl2TJdkBUaiXfKpPiwK9UyRCyhRR9HHP7ge80ccxJwjrJDqxUbFrnOhRxDFztfw19UaBFAVG_JVv6W2GREt-xtEGhk-DwN88MIdZmRXymp_Jq9hAbfXOd6YGWPmGllPkImlGAb0ABNB4ojkZq_TOm4ZSCukw==",
                "id": "rs_081a3fa942ee8eec016909222385b88197bb171701d5814168",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762206242,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 1523,
        "prompt_tokens": 157,
        "total_tokens": 1680,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 1472,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00308525,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 3.925e-05,
          "upstream_inference_completions_cost": 0.003046
        }
      },
      "provider": "OpenAI"
    }
  }
]